Giant cell arteritis, infections and biologics
Epidemiological studies showing an increased incidence of systemic vasculitis in people infected with a particular agent, while not wholly definitive, may strengthen the infection-induced autoimmunity concept. 1 In the impressive nested case-control study recently published in the Annals of the Rheu...
Saved in:
Published in | Annals of the rheumatic diseases Vol. 76; no. 9; p. e29 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
England
BMJ Publishing Group LTD
01.09.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Epidemiological studies showing an increased incidence of systemic vasculitis in people infected with a particular agent, while not wholly definitive, may strengthen the infection-induced autoimmunity concept. 1 In the impressive nested case-control study recently published in the Annals of the Rheumatic Diseases, 2 Rhee et al examined the relationship between any infection or herpes zoster infection and the development of giant cell arteritis (GCA) in a large cohort of patients (n=4559) and controls (n=22 759). [...]proof-of-concept trial may be justified to study whether antiviral treatment with acyclovir or valacyclovir confers additional benefit to patients with GCA receiving corticosteroids. Biological agents have different mechanisms of action and safety profiles. [...]it would be a mistake to assume that all of them increase the risk of infections compared with standard treatment. |
---|---|
Bibliography: | SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 ObjectType-Commentary-2 |
ISSN: | 0003-4967 1468-2060 |
DOI: | 10.1136/annrheumdis-2016-210955 |